a public good project by the
Synthesis
Company
of California

© 2026

Ping Wu | doi.page

0 works0 citations0 h-index

Ping Wu

Wenzhou Medical University(CN)First Affiliated Hospital of Wenzhou Medical University(CN)Zhejiang Lab(CN)

Publications by Year

Research Areas

Multiple Myeloma Research and Treatments, MicroRNA in disease regulation, Cancer Treatment and Pharmacology, Hepatitis B Virus Studies, Bone health and treatments

Most-Cited Works

→ Assessment of heavy metal pollution and human health risks in urban soils around an electronics manufacturing facility(2018)415 cited
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.(1996)
→ Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma(2013)164 cited
→ Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial(2011)162 cited
→ Circadian Modulation of Dopamine Levels and Dopaminergic Neuron Development Contributes to Attention Deficiency and Hyperactive Behavior(2015)143 cited
→ The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma(2014)132 cited

→ XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments(2010)120 cited

→ The impact of extramedullary disease at presentation on the outcome of myeloma(2009)112 cited

→ Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats(2011)104 cited

→ Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients(2007)102 cited